Stockscreener 앱 받기
1.95
9.55%
0.17
시간 외 거래:
1.97
0.02
+1.03%
Io Biotech Inc 주식(IOBT)의 최신 뉴스
Is IO Biotech Inc. forming bullish engulfing patternsJuly 2025 Pullbacks & Low Risk Entry Point Guides - 뉴스영
News impact scoring models applied to IO Biotech Inc.2025 Risk Factors & Safe Capital Allocation Plans - Newser
Pattern recognition hints at IO Biotech Inc. upsideTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - Newser
Short interest data insights for IO Biotech Inc.Wall Street Watch & Daily Oversold Bounce Ideas - Newser
Building trade automation scripts for IO Biotech Inc.2025 Market WrapUp & Weekly Chart Analysis and Guides - Newser
Will IO Biotech Inc. stock hit new highs in YEARDividend Hike & AI Powered Market Trend Analysis - خودرو بانک
IO Biotech says cancer vaccine with Merck’s Keytruda outperformed in late-stage study - MSN
IO Biotech’s vaccine misses on mPFS in phase III advanced melanoma trial - The Cancer Letter
What earnings revisions data tells us about IO Biotech Inc.Quarterly Portfolio Report & Long-Term Safe Return Strategies - Newser
Should you hold or exit IO Biotech Inc. nowWeekly Trade Review & Safe Entry Momentum Stock Tips - Newser
What data driven models say about IO Biotech Inc.’s futureOptions Play & Advanced Swing Trade Entry Plans - Newser
Is IO Biotech Inc. a top pick in the sectorTrade Entry Summary & Daily Profit Maximizing Trade Tips - خودرو بانک
Applying sector rotation models to IO Biotech Inc.Wall Street Watch & Daily Profit Focused Screening - Newser
Analyst Upgrade: Will IO Biotech Inc. stock hit new highs in YEAR2025 Market Trends & Weekly Chart Analysis and Guides - خودرو بانک
Using Ichimoku Cloud for IO Biotech Inc. technicalsMarket Risk Summary & Capital Efficient Trading Techniques - Newser
IO Biotech’s Strategic Momentum: Evaluating Cylembio’s Pipeline Progress and Investor Engagement as Catalysts for Long-Term Growth - AInvest
IO Biotech Announces Upcoming Investor Conferences and Corporate Update on Cylembio® Development - Quiver Quantitative
IO Biotech to Present at Upcoming Investor Conferences, Highlighting Cylembio Therapeutic Cancer Vaccine Candidate - AInvest
IO Biotech Announces Participation in Upcoming Investor Conferences - The Manila Times
Cancer Vaccine Developer IO Biotech to Present Latest Corporate Updates at Global Healthcare Forums - Stock Titan
Detecting support and resistance levels for IO Biotech Inc.Fed Meeting & Technical Pattern Alert System - Newser
How to track smart money flows in IO Biotech Inc.Trade Risk Summary & Daily Technical Forecast Reports - Newser
What are analysts’ price targets for IO Biotech Inc.July 2025 Update & High Conviction Trade Alerts - خودرو بانک
Price momentum metrics for IO Biotech Inc. explained2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Volatility clustering patterns for IO Biotech Inc.Market Trend Review & Safe Capital Preservation Plans - Newser
Will IO Biotech Inc. benefit from macro trendsIndex Update & Weekly High Return Stock Forecasts - Newser
Can a trend reversal in IO Biotech Inc. lead to recovery2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Analyzing recovery setups for IO Biotech Inc. investorsGDP Growth & Safe Capital Growth Plans - Newser
Is IO Biotech Inc. stock poised for growthRecession Risk & Verified Entry Point Detection - Newser
Using portfolio simulators with IO Biotech Inc. includedNew Guidance & Free Accurate Trade Setup Notifications - Newser
How liquid is IO Biotech Inc. stockJuly 2025 Technicals & Growth Focused Entry Reports - خودرو بانک
What to do if you’re stuck in IO Biotech Inc.Weekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
What to expect from IO Biotech Inc. in the next 30 days2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
How to integrate IO Biotech Inc. into portfolio analysis toolsJuly 2025 Breakouts & Verified High Yield Trade Plans - Newser
Can IO Biotech Inc. navigate macro headwindsJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - خودرو بانک
Does IO Biotech Inc. meet Warren Buffett’s criteria2025 Buyback Activity & Real-Time Volume Surge Alerts - خودرو بانک
Analyzing net buyer seller activity in IO Biotech Inc.July 2025 Market Mood & Verified Technical Trade Signals - Newser
Io Biotech, Inc. shares rise 6.39% intraday due to unspecified reasons. - AInvest
IO Biotech Inc. stock momentum explainedMarket Trend Review & Smart Allocation Stock Reports - Newser
1.40%
자본화:
|
볼륨(24시간):